Chemokine C10 promotes disease resolution and survival in an experimental model of bacterial sepsis

Infection and Immunity

Volumn 68, Issue 11, 2000, Pages 6108-6114

  Steinhauser, M L ^a   Hogaboam, C M ^a   Matsukawa, A ^a   Lukacs, N W ^a   Strieter, R M ^a   Kunkel, S L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; CHEMOKINE; CYTOKINE; INTERLEUKIN 13; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTERIAL PERITONITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HOST RESISTANCE; MOUSE; NONHUMAN; PERITONEUM LAVAGE; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; SEPSIS; SURVIVAL RATE;

ANIMAL; BACTEREMIA; CHEMOKINES, CC; FEMALE; IMMUNE SERA; INTERLEUKIN-1; INTERLEUKIN-13; MICE; MONOCYTE CHEMOATTRACTANT PROTEIN-1; PHAGOCYTOSIS; RABBITS; RECOMBINANT PROTEINS; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR NECROSIS FACTOR;

EID: 0033784259     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.11.6108-6114.2000     Document Type: Article

References (28)

1. Double blind randomized controlled trial of monoclonal antibody to human tumor necrosis factor in treatment of septic shock. NORASEPT II Study Group
2. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group
3. The chemokine C10: Immunological and functional analysis of the sequence encoded by the novel second exon
4. Sepsis and cytokines: Current status
5. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee American College of Chest Physicians Society of Critical Care Medicine
6. Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis
7. Incidence, risk factors and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units
8. INTERSEPT: An international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis
9. Critical protective role of mast cells in a model of acute septic peritonitis
10. A sensitive ELISA for the detection of human monocyte chemoattractant protein-1 (MCP-1)
11. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group
12. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group
13. Molecular cloning and functional characterization of a novel member of the C-C chemokine family
14. Immunomodulatory role of C10 chemokine in a murine model of allergic bronchopulmonary aspergillosis
15. Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: Cross-talk between MCP-1 and leukotriene B4
16. Expression and contribution of endogenous IL-13 in an experimental model of sepsis
17. Protection against lethal bacterial infection in mice by monocyte-chemotactic and -activating factor
18. Interleukin 1 beta improves survival following cecal ligation and puncture
19. Selective induction of the beta chemokine C10 by IL-4 in mouse macrophages
20. HCC-2, a human chemokine: Gene structure, expression pattern, and biological activity
21. Chemokines
22. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease
23. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense
24. Multiple roles for IL-12 in a model of acute septic peritonitis
25. Elevated levels of macrophage inflammatory protein 2 in severe murine peritonitis increase neutrophil recruitment and mortality
26. Balance of inflammatory cytokines related to severity and mortality of murine sepsis
27. Molecular cloning and functional characterization of human MIP-1 delta, a new C-C chemokine related to mouse CCF-18 and C10
28. Sustained high-level production of murine chemokine C10 during chronic inflammation